Based on the key measurements obtained from ABVC Biopharma's financial statements, ABVC Biopharma is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At present, ABVC Biopharma's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1.5 M, whereas Short and Long Term Debt Total is forecasted to decline to about 2 M.
Investors should never underestimate ABVC Biopharma's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to research ABVC Biopharma's cash flow, debt, and profitability to make informed and accurate decisions about investing in ABVC Biopharma.
Understanding current and past ABVC Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABVC Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in ABVC Biopharma's assets may result in an increase in income on the income statement.
Please note, the presentation of ABVC Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABVC Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABVC Biopharma's management manipulating its earnings.
ABVC Biopharma Stock Summary
ABVC Biopharma competes with Reviva Pharmaceuticals, Grace Therapeutics, PDS Biotechnology, Actinium Pharmaceuticals, and Jupiter Neurosciences. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining ABVC Biopharma's current stock value. Our valuation model uses many indicators to compare ABVC Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABVC Biopharma competition to find correlations between indicators driving ABVC Biopharma's intrinsic value. More Info.
ABVC Biopharma is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At present, ABVC Biopharma's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABVC Biopharma's earnings, one of the primary drivers of an investment's value.
Most indicators from ABVC Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ABVC Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
Today, most investors in ABVC Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ABVC Biopharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ABVC Biopharma growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.0157
At present, ABVC Biopharma's Price Earnings To Growth Ratio is projected to decrease significantly based on the last few years of reporting.
ABVC Biopharma February 13, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ABVC Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABVC Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABVC Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing ABVC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABVC Biopharma's daily price indicators and compare them against related drivers.
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.